Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Malaria vaccine: 3 or 6 months' protection?.
SMITH, PG; MILLIGAN, PJ;
2005
The Lancet, (2005).365 9458 10.1016/s0140-6736(05)17860-x.
Malaria vaccine: 3 or 6 months' protection?.
SMITH, PG; MILLIGAN, PJ;
2005
Lancet, (2005).365 9458 10.1016/S0140-6736(05)17860-X.
Epidemiologic, immunologic and practical considerations in developing and evaluating a human hookworm vaccine.
BROOKER, S; Bethony, JM; RODRIGUES, LC; ALEXANDER, N; Geiger, SM; Hotez, PJ;
2005
Expert review of vaccines, (2005).4 1 10.1586/14760584.4.1.35.
Influenza vaccination in Brazil: rationale and caveats.
Da Cunha, SS; Camacho, LA B; SANTOS, AC; Dourado, I;
2005
Revista de saude publica, (2005).39 1 10.1590/s0034-89102005000100017.
Bacteremia among children admitted to a rural hospital in Kenya.
Berkley, JA; Lowe, BS; Mwangi, I; Williams, T; Bauni, E; Mwarumba, S; Ngetsa, C; Slack, MP E; Njenga, S; Hart, CA; Maitland, K; English, M; Marsh, K; SCOTT, JA G;
2005
The New England journal of medicine, (2005).352 1 10.1056/NEJMoa040275.
Immunisation at the crossroads: 9th National Immunisation/1st Asia-Pacific Vaccine Preventable Diseases Conference.
McIntyre, PB; Kelly, HA; MULHOLLAND, EK;
2005
The Medical journal of Australia, (2005).182 1
Practical aspects of phase 3 vaccine trials in developing countries.
GREENWOOD, B;
2005
The Grand Challenge for the Future , Birkhauser Verlag (Basel) (2005).
Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial.
Gessner, BD; Sutanto, A; Linehan, M; Djelantik, IG G; Fletcher, T; Gerudug, IK; Ingerani,; Mercer, D; Moniaga, V; Moulton, LH; Moulton, LH; MULHOLLAND, K; Nelson, C; Soemohardjo, S; Steinhoff, M; Widjaya, A; Stoeckel, P; Maynard, J; Arjoso, S;
2005
Lancet, (2005).365 9453 10.1016/s0140-6736(04)17664-2.
IgG antibodies to merozoite surface antigens are associated with recovery from chloroquine (CQ)-resistant P. falciparum in Gambian children [MIM-CS-62139].
Pinder, M; SUTHERLAND, CJ; Sisay-Joof, F; Ismaili, J; McCall, MB B; Ord, R; Hallett, R; Holder, AA; Milligan, P;
2005
ACTA TROPICA, (2005).95,
Genetically engineered structure-based vaccine for bluetongue disease.
ROY, P;
2004
Veterinaria italiana, (2004).40 4